Robotic surgery (n = 55) | Laparoscopic surgery (n = 56) | Overall (n = 111) | P | |
---|---|---|---|---|
Age, median (IQR), years | 82(81–85) | 82(81–84) | 82(81–85) | 0.202 |
Gender, n (%) | 0.294 | |||
Male | 31(56.4) | 37(66.1) | 68(61.3) | |
Female | 24(43.6) | 19(33.9) | 43(38.7) | |
BMI, mean (SD), kg/m2 | 23.8(3.6) | 23.3(2.7) | 23.5(3.2) | 0.362 |
ASA score, n (%) | 0.782 | |||
II | 26(47.3) | 30(53.6) | 56(50.6) | |
III | 28(50.9) | 25(44.6) | 53(47.7) | |
IV | 1(1.8) | 1(1.8) | 2(1.8) | |
Previous abdominal surgery, n (%) | 10(18.2) | 24(42.9) | 34(30.6) | 0.005 |
Hepatobiliary surgery | 5(9.1) | 6(10.7) | 11(9.9) | |
Gynecological surgery | 2(3.6) | 7(12.5) | 9(8.1) | |
Appendectomy | 4(7.3) | 11(19.6) | 15(13.5) | |
Anterior resection | 0(0) | 1(1.8) | 1(0.9) | |
Inguinal herniorrhaphy | 0(0) | 2(3.6) | 2(1.8) | |
Urological surgery | 1(1.8) | 1(1.8) | 2(1.8) | |
Comorbidity, n (%) | 44(80.0) | 32(57.1) | 76(68.5) | 0.010 |
Coronary heart disease | 12(21.8) | 11(19.6) | 23(20.7) | |
Diabetes | 12(21.8) | 6(10.7) | 18(16.2) | |
Cerebrovascular disease | 10(18.2) | 6(10.7) | 16(14.4) | |
Hepatitis | 2(3.6) | 2(3.6) | 4(3.6) | |
Renal disease | 4(7.3) | 2(3.6) | 6(5.4) | |
Hypertension | 30(54.5) | 27(48.2) | 57(51.4) | |
Pulmonary disease | 4(7.3) | 3(5.4) | 7(7.6) | |
Synchronous tumor*, n (%) | 4(7.3) | 5(8.9) | 9(8.1) | > 0.999 |
ACCI, mean (SD) | 7.1(1.1) | 7.2(1.8) | 7.2(1.5) | 0.505 |
Neoadjuvant therapy, n (%) | 2(3.6) | 0(0) | 2(1.8) | 0.243 |
Tumor location, n (%) | 0.391 | |||
Ascending colon | 16(29.1) | 19(33.9) | 35(31.5) | |
Transverse colon | 0(0) | 2(3.6) | 2(1.8) | |
Descending colon | 2(3.6) | 1(1.8) | 3(2.7) | |
Sigmoid colon | 13(23.6) | 16(28.6) | 29(26.1) | |
Rectum | 22(40.0) | 15(26.8) | 37(33.3) | |
Other** | 2(3.6) | 3(5.4) | 5(4.5) | |
Serum CEA, median (IQR), μg/L | 4.4(2.6–9.9) | 7.3(3.3–20.8) | 5.5(2.9–13.4) | 0.754 |
Missing data, n (%) | 0(0) | 1(1.8) | 1(0.9) | |
Serum CA19-9, median (IQR), u/mL | 14.3(7.8–20.5) | 18.9(8.9–42.6) | 15.8(8.6–29.4) | 0.079 |
Missing data, n (%) | 0(0) | 1(1.8) | 1(0.9) | |
Serum CA724, median (IQR), u/mL | 2.7(1.6–5.2) | 2.3(1.4–6.6) | 2.6(1.4–5.3) | 0.805 |
Missing data, n (%) | 3(5.5) | 5(8.9) | 8(7.2) | |
Serum CA125, median (IQR), u/mL | 11.3(8.0–18.8) | 12.4(8.8–16.3) | 11.6(8.4–18.1) | 0.803 |
Missing data, n (%) | 1(1.8) | 3(5.4) | 4(3.6) |